![Richard Pulik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Pulik
Finansdirektör/CFO på
ROIVANT SCIENCES LTD.
Förmögenhet: 10 M $ per 2026-06-30
Profil
Richard Pulik is currently Chief Financial Officer at Roivant Sciences Ltd. and Roivant Sciences, Inc., both positions started in 2021.
Former roles include Member-Management Board at Novartis Oncology, Inc., and Global Head-Business Development & Licensing at Novartis AG from 2019 to 2021.
Education includes undergraduate degrees from the University of Pennsylvania and The Wharton School of the University of Pennsylvania.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ROIVANT SCIENCES LTD. 0,04 % | 2026-06-20 | 276 420 ( 0,04 % ) | 10 M $ | 2026-06-30 |
Aktiva positioner av Richard Pulik
| Företag | Position | Start |
|---|---|---|
| ROIVANT SCIENCES LTD. | Finansdirektör/CFO | 2021-09-28 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Finansdirektör/CFO | 2021-09-28 |
Tidigare kända positioner av Richard Pulik
| Företag | Position | Slut |
|---|---|---|
| NOVARTIS AG | Investor Relations Kontakt | 2019-08-01 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Företagsledare/Principal | - |
Richard Puliks utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
96
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Roivant Sciences Ltd.
 Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
